{"title":"Tissue Repair \u0026 Recovery Research Peptides UK","description":"\u003cp\u003eExplore our range of \u003cstrong\u003etissue repair and recovery research peptides\u003c\/strong\u003e, supplied to UK researchers for in vitro laboratory investigation. This collection includes some of the most extensively studied regenerative compounds in preclinical science — including BPC-157, TB-500, the BPC-157 + TB-500 combination blend, and KPV — each manufactured to ≥99% purity and independently verified via HPLC.\u003c\/p\u003e\u003cp\u003eThese peptides are investigated for their roles in angiogenesis, tendon-to-bone healing, skeletal muscle regeneration, gastrointestinal mucosal protection, and anti-inflammatory signalling. All products are supplied as lyophilised powder in vial or 3ml cartridge format, with certificates of analysis available for every batch. Fast 1–2 day UK delivery via Royal Mail with full tracking.\u003c\/p\u003e\u003cp\u003e\u003cem\u003eAll products are supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary use.\u003c\/em\u003e\u003c\/p\u003e","products":[{"product_id":"bpc-157","title":"Buy BPC-157 Research Peptide UK | 99%+ Purity","description":"\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e (Body Protection Compound-157; sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) is a synthetic pentadecapeptide derived from a body protection compound found in human gastric juice. It is one of the most extensively studied regenerative peptides in preclinical science, investigated for its roles in angiogenesis, tendon-to-bone healing, skeletal muscle regeneration, and gastrointestinal mucosal protection.\u003c\/p\u003e\u003cp\u003eBPC-157 has been shown in preclinical models to modulate VEGF, EGF, and nitric oxide signalling pathways, while also influencing dopaminergic and serotonergic neurotransmission. Its exceptional stability in human gastric juice and broad preclinical activity profile make it one of the most studied compounds in regenerative and GI research.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eCAS:\u003c\/strong\u003e 137525-51-0  ·  \u003cstrong\u003eFormula:\u003c\/strong\u003e C62H98N16O22  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 1419.5 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Tissue regeneration · Angiogenesis · GI mucosal biology · Tendon \u0026amp; ligament repair · Wound healing · Nitric oxide signalling · Neurological models\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\" target=\"_blank\" rel=\"noopener\"\u003eAlkali-burn wound healing and angiogenesis in vivo (PMID 25995620)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32334036\/\" target=\"_blank\" rel=\"noopener\"\u003ePreclinical safety evaluation of BPC-157 (PMID 32334036)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40005999\/\" target=\"_blank\" rel=\"noopener\"\u003eMultifunctionality and medical application review (PMID 40005999)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=BPC-157+pentadecapeptide+tissue\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg \/ Vial","offer_id":53108990312781,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true},{"title":"10mg \/ Vial","offer_id":53108990345549,"sku":null,"price":40.0,"currency_code":"GBP","in_stock":true},{"title":"5mg \/ 3ml Cartridge","offer_id":54416687464781,"sku":null,"price":30.0,"currency_code":"GBP","in_stock":true},{"title":"10mg \/ 3ml Cartridge","offer_id":54416687497549,"sku":null,"price":45.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/BPC1575mgBox-M.jpg?v=1770811988"},{"product_id":"bpc157-tb500","title":"Buy BPC-157 + TB-500 Blend UK | Recovery Research Peptide","description":"\u003cp\u003e\u003cstrong\u003eBPC-157 + TB-500\u003c\/strong\u003e is a research peptide combination pairing two of the most studied tissue-repair compounds in preclinical science. BPC-157 (CAS 137525-51-0) is a gastric-derived pentadecapeptide studied for angiogenesis, GI mucosal protection, and musculoskeletal healing. TB-500 (the active actin-sequestering fragment of Thymosin β4; parent compound CAS 107761-42-2) is studied for cellular migration, connective tissue repair, and cardiac regeneration pathways.\u003c\/p\u003e\u003cp\u003eThe combination is frequently investigated in preclinical recovery research due to their complementary and potentially synergistic mechanisms: BPC-157 primarily through NO-system modulation and growth factor signalling, and TB-500 through actin sequestration and LKKTETQ-domain-mediated cell migration. Available in 10 mg and 20 mg formats.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eBPC-157 CAS:\u003c\/strong\u003e 137525-51-0  ·  \u003cstrong\u003eTB-500 (Thymosin β4) CAS:\u003c\/strong\u003e 107761-42-2  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC (each component)  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder blend  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Synergistic tissue repair · Angiogenesis · Musculoskeletal recovery · GI mucosal biology · Cardiac regeneration models · Cellular migration\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\" target=\"_blank\" rel=\"noopener\"\u003eBPC-157: wound healing and angiogenesis in vivo (PMID 25995620)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10469335\/\" target=\"_blank\" rel=\"noopener\"\u003eThymosin beta4 accelerates wound healing (PMID 10469335)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\"\u003eActin binding site of thymosin beta4 promotes angiogenesis (PMID 14500546)\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg \/ Vial","offer_id":53109160018253,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":false},{"title":"10mg \/ 3ml Cartridge","offer_id":54424412619085,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":false},{"title":"20mg \/ Vial","offer_id":53425628479821,"sku":null,"price":80.0,"currency_code":"GBP","in_stock":true},{"title":"20mg \/ 3ml Cartridge","offer_id":54424412651853,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/BPC1575mgBox-M_a4d627c9-c3f6-4529-a4d8-a3e857df1e4d.jpg?v=1770812387"},{"product_id":"tb-500","title":"Buy TB-500 Research Peptide UK | 99%+ Purity | Tissue Repair","description":"\u003cp\u003e\u003cstrong\u003eTB-500 (889)\u003c\/strong\u003e is a synthetic version of the actin-sequestering active region of Thymosin β4, corresponding to the LKKTETQ heptapeptide motif (amino acids 17–23 of full-length Thymosin β4; parent protein CAS 107761-42-2). The 889 designation refers to the specific fragment studied extensively for its role in cellular migration, angiogenesis, and tissue-response pathways.\u003c\/p\u003e\u003cp\u003eResearch has established that the LKKTETQ actin-binding domain is primarily responsible for the wound-healing and angiogenic activity observed with full-length Thymosin β4. TB-500 sequesters G-actin, reducing the intracellular G\/F-actin ratio and thereby promoting cell motility, blood vessel formation, and matrix remodelling. Studies have documented activity in cardiac regeneration, skin wound healing, and musculoskeletal repair models.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eParent Compound CAS:\u003c\/strong\u003e 107761-42-2 (Thymosin β4)  ·  \u003cstrong\u003eActive Fragment:\u003c\/strong\u003e Ac-LKKTETQ-OH  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e Actin sequestration · Cellular migration · Wound healing · Angiogenesis · Cardiac repair models · Connective tissue repair\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSelected Research Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10469335\/\" target=\"_blank\" rel=\"noopener\"\u003eThymosin beta4 accelerates wound healing (PMID 10469335)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14500546\/\" target=\"_blank\" rel=\"noopener\"\u003eActin binding site of thymosin beta4 promotes angiogenesis (PMID 14500546)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38382158\/\" target=\"_blank\" rel=\"noopener\"\u003eTB-500 metabolites and wound healing activity in vitro (PMID 38382158)\u003c\/a\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=thymosin+beta-4+TB-500+wound+healing+actin\" target=\"_blank\" rel=\"noopener\"\u003eFull PubMed literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"5mg","offer_id":53109181382989,"sku":null,"price":25.0,"currency_code":"GBP","in_stock":true},{"title":"10mg","offer_id":53109181415757,"sku":null,"price":50.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/TB50010mgBox-M.jpg?v=1770812200"},{"product_id":"kpv","title":"Buy KPV Research Peptide UK | 99%+ Purity | Anti-Inflammatory","description":"\u003cp\u003e\u003cstrong\u003eKPV\u003c\/strong\u003e (Lys-Pro-Val; α-MSH residues 11–13) is the C-terminal tripeptide of alpha-melanocyte stimulating hormone (α-MSH). While short, KPV retains the principal anti-inflammatory bioactivity of the parent 13-residue peptide, acting primarily via MC1R-mediated pathways to suppress NF-κB activation and pro-inflammatory cytokine release (TNF-α, IL-1β, IL-6) in immune and epithelial cell models.\u003c\/p\u003e\u003cp\u003eResearch has demonstrated KPV's anti-inflammatory efficacy in models of colitis, skin inflammation, and wound healing. Its small molecular size, resistance to proteolysis (conferred by the C-terminal valine), and ability to modulate both innate immune and adaptive inflammatory responses make it a highly versatile research peptide. It has been explored for delivery via oral and topical routes in preclinical models.\u003c\/p\u003e\u003cp style=\"font-size:0.875em;border:1px solid #dde6f0;padding:10px;border-radius:4px;\"\u003e\u003cstrong\u003eSequence:\u003c\/strong\u003e H-Lys-Pro-Val-OH (α-MSH 11–13)  ·  \u003cstrong\u003eMW:\u003c\/strong\u003e 341.4 g\/mol  ·  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% HPLC  ·  \u003cstrong\u003eFormat:\u003c\/strong\u003e Lyophilised powder  ·  \u003cstrong\u003eStorage:\u003c\/strong\u003e −20 °C\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Areas:\u003c\/strong\u003e MC1R-mediated anti-inflammatory signalling · NF-κB suppression · Cytokine inhibition · Inflammatory bowel disease models · Wound healing · Skin inflammation\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch Literature:\u003c\/strong\u003e\u003cbr\u003e• \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=KPV+alpha-MSH+anti-inflammatory+melanocortin+tripeptide\" target=\"_blank\" rel=\"noopener\"\u003ePubMed: KPV research literature →\u003c\/a\u003e\u003c\/p\u003e\u003cp style=\"background:#eef4fb;border-left:3px solid #0b4a7c;padding:10px 14px;margin-bottom:1em;font-size:0.875em;\"\u003e\u003cstrong\u003eMulti-Buy Savings\u003c\/strong\u003e — Add 2+ products to save 4% automatically. Add 3+ to save 6%. Applied at checkout.\u003c\/p\u003e\u003cp style=\"background:#fff8e6;border-left:3px solid #e6a817;padding:10px 14px;font-size:0.8em;line-height:1.5;margin-top:1em;\"\u003e\u003cstrong\u003eResearch Use Only.\u003c\/strong\u003e Supplied strictly for in vitro laboratory research by qualified professionals. Not for human or veterinary administration. Not evaluated by the MHRA or FDA for therapeutic use. Researchers must comply with the Human Medicines Regulations 2012 and all applicable institutional guidelines. Peptide Biosciences accepts no liability for use outside a controlled research context.\u003c\/p\u003e","brand":"Peptide Biosciences","offers":[{"title":"10mg","offer_id":54279578976589,"sku":null,"price":37.5,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/8846\/2669\/files\/kpv.png?v=1783835423"}],"url":"https:\/\/www.peptide-biosciences.com\/collections\/tissue-repair-recovery-research-peptides-uk.oembed","provider":"Peptide Biosciences","version":"1.0","type":"link"}